These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9550388)

  • 21. Mixed haplotype A beta Z/A alpha d class II molecule in (NZB x NZW)F1 mice detected by T cell clones.
    Gotoh Y; Takashima H; Noguchi K; Nishimura H; Tokushima M; Shirai T; Kimoto M
    J Immunol; 1993 Jun; 150(11):4777-87. PubMed ID: 8496588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor kappa B cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumors.
    Lee JM; Mahtabifard A; Yamada R; Crystal RG; Korst RJ
    Clin Cancer Res; 2002 Nov; 8(11):3561-9. PubMed ID: 12429647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional sites on the A alpha-chain. Polymorphic residues involved in antigen presentation to insulin-specific, Ab alpha:Ak beta-restricted T cells.
    Reske-Kunz AB; Landais D; Peccoud J; Benoist C; Mathis D
    J Immunol; 1989 Sep; 143(5):1472-81. PubMed ID: 2474599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-function analysis of the Abm12 beta mutation using site-directed mutagenesis and DNA-mediated gene transfer.
    Ronchese F; Brown MA; Germain RN
    J Immunol; 1987 Jul; 139(2):629-38. PubMed ID: 3110276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MHC class II proteins contain a potential binding site for the verotoxin receptor glycolipid CD77.
    George T; Boyd B; Price M; Lingwood C; Maloney M
    Cell Mol Biol (Noisy-le-grand); 2001 Nov; 47(7):1179-85. PubMed ID: 11838965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hybrid membrane IgM with the transmembrane region of I-A alpha facilitates enhanced presentation of distinct epitopes to T cells.
    Liu KJ; Schwen M; Tucker PW; Kim BS
    J Immunol; 1998 May; 160(9):4161-8. PubMed ID: 9574515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrosarcoma cells expressing allogeneic MHC Class II antigens induce protective antitumor immunity.
    Leach DR; Callahan GN
    J Immunol; 1995 Jan; 154(2):738-43. PubMed ID: 7814880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Invariant chain and the MHC class II cytoplasmic domains regulate localization of MHC class II molecules to lipid rafts in tumor cell-based vaccines.
    Dolan BP; Phelan TP; Ilkovitch D; Qi L; Wade WF; Laufer TM; Ostrand-Rosenberg S
    J Immunol; 2004 Jan; 172(2):907-14. PubMed ID: 14707062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MHC class II-transfected tumor cells directly present antigen to tumor-specific CD4+ T lymphocytes.
    Armstrong TD; Clements VK; Ostrand-Rosenberg S
    J Immunol; 1998 Jan; 160(2):661-6. PubMed ID: 9551900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory.
    Mortara L; Castellani P; Meazza R; Tosi G; De Lerma Barbaro A; Procopio FA; Comes A; Zardi L; Ferrini S; Accolla RS
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3435-43. PubMed ID: 16740768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphism at position nine of the MHC class I heavy chain affects the stability of association with beta 2-microglobulin and presentation of a viral peptide.
    Ribaudo RK; Margulies DH
    J Immunol; 1995 Oct; 155(7):3481-93. PubMed ID: 7561043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thymic positive selection and peripheral activation of islet antigen-specific T cells: separation of two diabetogenic steps by an I-A(g7) class II MHC beta-chain mutant.
    Kanagawa O; Vaupel BA; Xu G; Unanue ER; Katz JD
    J Immunol; 1998 Nov; 161(9):4489-92. PubMed ID: 9794372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Staphylococcal enterotoxin H displays unique MHC class II-binding properties.
    Nilsson H; Björk P; Dohlsten M; Antonsson P
    J Immunol; 1999 Dec; 163(12):6686-93. PubMed ID: 10586065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
    De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K
    J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mixed-haplotype MHC class II molecules select functional CD4+ T cells.
    Silk JD; Schoendorf D; Bartok I; Chai JG; Gray D; Simpson E; Dyson J
    Mol Immunol; 2005 Jun; 42(10):1129-39. PubMed ID: 15829303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Invariant chain alters the malignant phenotype of MHC class II+ tumor cells.
    Clements VK; Baskar S; Armstrong TD; Ostrand-Rosenberg S
    J Immunol; 1992 Oct; 149(7):2391-6. PubMed ID: 1527384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ek beta mutant antigen-presenting cell lines expressing altered Ak alpha molecules.
    Quill H; Schwartz RH; Glimcher LH
    J Immunol; 1986 May; 136(9):3351-9. PubMed ID: 3082986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A three-amino-acid-long HLA-DRbeta cytoplasmic tail is sufficient to overcome ER retention of invariant-chain p35.
    Khalil H; Brunet A; Thibodeau J
    J Cell Sci; 2005 Oct; 118(Pt 20):4679-87. PubMed ID: 16188937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytotoxic CD4+ T cells associated with the expression of major histocompatibility complex class II antigen of mouse myeloma cells secreting interferon-gamma are cytolytic in vitro and tumoricidal in vivo.
    Xiang J; Moyana T
    Cancer Gene Ther; 1998; 5(5):313-20. PubMed ID: 9824051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of APC in the selection of immunodominant T cell epitopes.
    Ma C; Whiteley PE; Cameron PM; Freed DC; Pressey A; Chen SL; Garni-Wagner B; Fang C; Zaller DM; Wicker LS; Blum JS
    J Immunol; 1999 Dec; 163(12):6413-23. PubMed ID: 10586031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.